Bio-Rad Laboratories, Inc.
BIO NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 4, 2026
ET
EPS Est.
1.75
EPS Actual
2.62
Revenue Est.
$624M
Revenue Actual
$651M
Next Earnings Report Date unconfirmed
Date
Oct 29, 2026 · Thu
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
2.23
Revenue Est.
$650.6M
Company Overview
Bio-Rad Laboratories, Inc. (ticker BIO) is listed on NYSE with a market cap of about $10.23B. Its next earnings report (FY2026 Q3) is expected on Oct 29, 2026 (ET), After-market (date pending company confirmation), with consensus EPS of 2.23. In the last 15 reported quarters, EPS beat consensus estimates 10 times.
Actual EPS TrendRecently15Term · Feb 16, 2023 → Aug 4, 2026
Feb 16, 2023Range: 1.89 ~ 3.34Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | 1.75 | Above forecast↑2.62 | $624M | $651M |
| Apr 30, 2026 | -- | 1.97 | 1.89 | $589.9M | $592.1M |
| Feb 12, 2026 | -- | 2.57 | 2.51 | $688.8M | $693.2M |
| Oct 29, 2025 | -- | 2.30 | 2.26 | $694.6M | $653M |
| Jul 31, 2025 | -- | 1.93 | Above forecast↑2.61 | $633.8M | $651.6M |
| May 1, 2025 | -- | 1.73 | Above forecast↑2.54 | $573.2M | $585.4M |
| Feb 13, 2025 | -- | 2.86 | 2.90 | $679.8M | $667.5M |
| Oct 30, 2024 | -- | 1.28 | Above forecast↑2.01 | $681.3M | $649.7M |
| Aug 1, 2024 | -- | 2.12 | Above forecast↑3.11 | $645.8M | $638.5M |
| May 7, 2024 | -- | 2.15 | 2.29 | $619.1M | $610.8M |
| Feb 15, 2024 | -- | 2.93 | 3.10 | $685.1M | $681.2M |
| Oct 26, 2023 | -- | 2.87 | Below forecast↓2.33 | $689.6M | $632.1M |
| Aug 3, 2023 | -- | 2.55 | Above forecast↑3.00 | $698M | $681.1M |
| May 4, 2023 | -- | 3.24 | 3.34 | $689.8M | $676.8M |
| Feb 16, 2023 | -- | 3.45 | 3.31 | $742.3M | $730.3M |
Original Filings (SEC)
10-Q2026-08-04 ↗
8-K2026-08-04 ↗
10-Q2026-04-30 ↗
8-K2026-04-30 ↗
8-K2026-04-24 ↗
8-K2026-02-19 ↗
10-K2026-02-13 ↗
8-K2026-02-12 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
